Tamoxifen Citrate
Inquiry
| Post Date: | Jan 20,2017 |
| Expiry Date: | Jul 19,2017 |
| Detailed Description: |
Cas No. :54965-24-1
Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, 4-hydroxytamoxifen.
In other tissues such as the endometrium, Tamoxifen behaves as an agonist, and thus may be characterized as a selective estrogen-receptor modulator. Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. |
| CAS Registry Number: | 54965-24-1 |
| Synonyms: | ;(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate;1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;Tamoxiphen Citrate;2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt); |
| Molecular Formula: | C32H34NO8 |
| Molecular Weight: | 560.6159 |
| Molecular Structure: | 
|
| Hazard Symbols: |  T:Toxic; |
| Risk Codes: | R22:; R45:; |
| Safety Description: | S45:; S53:; |
| Company: | HongKong Blue Universal Co., Limited. [ China ] |
| Contact: | ElleFiled |
| Tel: | +8615658039754 |
| Fax: | |
| Email: | ElleFiled@hotmail.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
